Yüklüyor......

Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status

BACKGROUND: Percutaneous ablation is a common treatment for colorectal liver metastases (CLM). However, the effect of RAS mutation on outcome after ablation of CLMs is unclear. METHODS: Patients who underwent image-guided percutaneous ablation of CLMs from 2004 through 2015 and had known Rat sarcoma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Surg
Asıl Yazarlar: Odisio, Bruno C., Yamashita, Suguru, Huang, Steven Y., Harmoush, Samer, Kopetz, Scott E., Ahrar, Kamran, Chun, Yun Shin, Conrad, Claudius, Aloia, Thomas A., Gupta, Sanjay, Hicks, Marshall E., Vauthey, Jean-Nicolas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391264/
https://ncbi.nlm.nih.gov/pubmed/28240361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.10490
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!